Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

Apotex conducting early studies on oral chelating agents

Oct. 27, 1998

RPR presents clinical findings with gpIIb/IIIa antagonist; product dropped due to dosing problems

Oct. 27, 1998

Sublingual apomorphine safe and effective in PD patients with motor fluctuations

Oct. 26, 1998

Transdermal selegiline as monotherapy in mild to moderate Parkinson's disease

Oct. 26, 1998

Transdermal D2 agonist therapy with N-0923 safe and effective in PD

Oct. 26, 1998

Glycolipid derivative shows cardioprotective activity in animal models

Oct. 26, 1998

Platelet collagen receptors targeted for development of new antiplatelet therapies

Oct. 23, 1998

Botulinum toxin type F useful in type A-resistant patients with dystonia

Oct. 23, 1998

Effects of DX-9065a on platelet activation reported at international congress

Oct. 23, 1998

Efficacy and safety demonstrated for rasagiline as adjunct to levodopa in PD

Oct. 23, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...